| Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts GA Ulaner, JF Hu, TH Vu, LC Giudice, AR Hoffman Cancer research 58 (18), 4168-4172, 1998 | 678 | 1998 |
| HER kinase inhibition in patients with HER2-and HER3-mutant cancers DM Hyman, SA Piha-Paul, H Won, J Rodon, C Saura, GI Shapiro, D Juric, ... Nature 554 (7691), 189-194, 2018 | 674 | 2018 |
| Ado-trastuzumab emtansine for patients with HER2-mutant lung cancers: results from a phase II basket trial BT Li, R Shen, D Buonocore, ZT Olah, A Ni, MS Ginsberg, GA Ulaner, ... Journal of Clinical Oncology 36 (24), 2532, 2018 | 480 | 2018 |
| Vemurafenib for BRAF V600–mutant Erdheim-Chester disease and Langerhans cell histiocytosis: analysis of data from the histology-independent, phase 2, open-label VE-BASKET study EL Diamond, V Subbiah, AC Lockhart, JY Blay, I Puzanov, I Chau, ... JAMA oncology 4 (3), 384-388, 2018 | 357 | 2018 |
| Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium GA Ulaner, JF Hu, TH Vu, H Oruganti, LC Giudice, AR Hoffman International journal of cancer 85 (3), 330-335, 2000 | 264 | 2000 |
| Efficacy of MEK inhibition in patients with histiocytic neoplasms EL Diamond, BH Durham, GA Ulaner, E Drill, J Buthorn, M Ki, L Bitner, ... Nature 567 (7749), 521-524, 2019 | 261 | 2019 |
| IVF results in de novo DNA methylation and histone methylation at an Igf2-H19 imprinting epigenetic switch T Li, TH Vu, GA Ulaner, E Littman, JQ Ling, HL Chen, JF Hu, B Behr, ... Molecular human reproduction 11 (9), 631-640, 2005 | 220 | 2005 |
| Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma GA Ulaner, HY Huang, J Otero, Z Zhao, L Ben-Porat, JM Satagopan, ... Cancer Research 63 (8), 1759-1763, 2003 | 220 | 2003 |
| Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site GA Ulaner, TH Vu, T Li, JF Hu, XM Yao, Y Yang, R Gorlick, P Meyers, ... Human molecular genetics 12 (5), 535-549, 2003 | 217 | 2003 |
| Developmental regulation of telomerase activity in human fetal tissues during gestation. GA Ulaner, LC Giudice Molecular human reproduction 3 (9), 769-773, 1997 | 198 | 1997 |
| Tissue‐specific alternate splicing of human telomerase reverse transcriptase (hTERT) influences telomere lengths during human development GA Ulaner, JF Hu, TH Vu, LC Giudice, AR Hoffman International journal of cancer 91 (5), 644-649, 2001 | 189 | 2001 |
| Detection of HER2-positive metastases in patients with HER2-negative primary breast cancer using 89Zr-trastuzumab PET/CT GA Ulaner, DM Hyman, DS Ross, A Corben, S Chandarlapaty, S Goldfarb, ... Journal of Nuclear Medicine 57 (10), 1523-1528, 2016 | 182 | 2016 |
| HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers BT Li, F Michelini, S Misale, E Cocco, L Baldino, Y Cai, S Shifman, HY Tu, ... Cancer discovery 10 (5), 674-687, 2020 | 175 | 2020 |
| Molecular classification of breast cancer E Provenzano, GA Ulaner, SF Chin PET clinics 13 (3), 325-338, 2018 | 169 | 2018 |
| Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphoma CS Sauter, MJ Matasar, J Meikle, H Schoder, GA Ulaner, JC Migliacci, ... Blood, The Journal of the American Society of Hematology 125 (16), 2579-2581, 2015 | 146 | 2015 |
| First-in-human human epidermal growth factor receptor 2–targeted imaging using 89Zr-Pertuzumab PET/CT: dosimetry and clinical application in patients with breast cancer GA Ulaner, SK Lyashchenko, C Riedl, S Ruan, PB Zanzonico, D Lake, ... Journal of Nuclear Medicine 59 (6), 900-906, 2018 | 143* | 2018 |
| Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms BH Durham, E Lopez Rodrigo, J Picarsic, D Abramson, V Rotemberg, ... Nature medicine 25 (12), 1839-1842, 2019 | 137 | 2019 |
| High prevalence of myeloid neoplasms in adults with non–Langerhans cell histiocytosis M Papo, EL Diamond, F Cohen-Aubart, JF Emile, D Roos-Weil, N Gupta, ... Blood, The Journal of the American Society of Hematology 130 (8), 1007-1013, 2017 | 112 | 2017 |
| Comparison of 18F-FDG PET/CT for systemic staging of newly diagnosed invasive lobular carcinoma versus invasive ductal carcinoma MP Hogan, DA Goldman, B Dashevsky, CC Riedl, M Gönen, JR Osborne, ... Journal of Nuclear Medicine 56 (11), 1674-1680, 2015 | 109 | 2015 |
| Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer LM Smyth, SA Piha-Paul, HH Won, AM Schram, C Saura, S Loi, J Lu, ... Cancer discovery 10 (2), 198-213, 2020 | 107 | 2020 |
